Is Zydus Wellness (ZYDUSWELL) overvalued or fairly valued?

MarketChacha shows Zydus Wellness's valuation in context — a forward P/E of about 32.7, a price-to-book of about 3.1 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is Zydus Wellness's revenue?

Zydus Wellness reported revenue of ₹3,961 Cr for FY2026, with net profit of ₹197 Cr, per official filings.

What is the share price of Zydus Wellness (ZYDUSWELL)?

Zydus Wellness last traded at ₹571.80 (-5.1% on the day), as of 7/22/2026 — a delayed quote shown for education, not investment advice.

Zydus Wellness

ZYDUSWELL · NSE · FMCG · India

₹571.80-5.1%

Delayed · as reported by Yahoo Finance · as of Jul 22, 2026, 10:00 AM

Snapshot

TickerZYDUSWELL

ExchangeNSE

SectorFMCG

IndustryPackaged Foods

CountryIndia

Employees1,685

HeadquartersAhmedabad, India

Market cap₹18,192 Cr

P/B3.1

Volume2.29L

Websitewww.zyduswellness.com

Filings tracked0

About Zydus Wellness

Zydus Wellness Limited engages in the development, production, marketing, and distribution of health and wellness products in India, the Middle East, Asia, Africa, the Oceania, and internationally. It provides sugar substitute products under the Sugar Free Gold, Sugar Free Natura, and Sugar Free Green brands; milk-based health food drink under the Complan brand; glucose-based beverage under the Glucon-D brand; and I'm lite a blended sugar coated with stevia. The company also offers a range of skincare products, such as soap-free face washes, face masks, scrubs, and leave-on-products under the Everyuth brand; prickly heat and cooling powder, and hand sanitizer under the Nycil brand; and probiotic butter spread, table spread, ghee, butter, cholesterol fat-free spread, mayonnaise, and chocolate spread under the Nutralite brand. It also exports its products. The company was formerly known as Carnation Nutra Analogue Foods Limited and changed its name to Zydus Wellness Limited in January 2009. The company was founded in 1988 and is headquartered in Ahmedabad, India. Zydus Wellness Limited is a subsidiary of Zydus Lifesciences Limited.

Profile as reported by Yahoo Finance.

Who owns it

Promoters69.8%
Institutions20.9%
Public & other9.3%

44 institutional holders

As reported by Yahoo Finance. Promoter pledge is not included here — that comes from exchange shareholding filings.

Forensic scorecard

Margin has compressed by about 8.8 points over the period — profitability is trending down.

Net margin trend13.8% → 5.0%

Margin has compressed by about 8.8 points over the period — profitability is trending down.

Growth qualityrev 21% · PAT -14%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (Yahoo Finance). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev ₹1,145 Cr · EPS 0.30

Est. earnings growth +151.3%

Next fiscal year

Rev ₹6,063 Cr · EPS 17.49

Est. earnings growth +30.3%

Analyst consensus estimates — not the company's own guidance. As reported by Yahoo Finance.

₹367.5552-wk range₹611.85

Delayed · as reported by Yahoo Finance

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: Yahoo Finance

Annual

Quarterly · last 4

Market cap

₹18,192 Cr

Day change

-5.1%

Fwd P/E

32.7

P/B

3.1

Div yield

0.20%

Beta

-0.09

Revenue (FY2026)

₹3,961 Cr

Net margin

5.0%

Revenue CAGR (3y)

+20.7%

Profit CAGR (3y)

-14.0%

Net profit (FY2026)

₹197 Cr

Market figures: Delayed · as reported by Yahoo Finance. Financials as reported in company filings.

Ask MarketChacha about ZYDUSWELL

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

Period	Revenue	Net profit	Net margin
FY2026	₹3,961 Cr	₹197 Cr	5.0%
FY2025	₹2,709 Cr	₹347 Cr	12.8%
FY2024	₹2,328 Cr	₹267 Cr	11.5%
FY2023	₹2,255 Cr	₹310 Cr	13.8%

Quarterly

Period	Revenue	Net profit	Net margin
2026Q1	₹1,485 Cr	₹162 Cr	10.9%
2025Q4	₹965 Cr	₹-40 Cr	-4.1%
2025Q3	₹651 Cr	₹-53 Cr	-8.1%
2025Q2	₹861 Cr	—	—

Figures as reported, in ₹ (crore). Source: Yahoo Finance.

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.